Abstract
Type II diabetes Mellitus is one of the common diseases worldwide and often recognized as life style disease. The major symptom of this disease is an increase in blood glucose level resulting in polydypsia, polyuria and polyphagia. Molecular modeling was used to design the drug molecules. Docking results showed imidazolidine derivatives have good interaction with the DPP IV receptors. The compound IMA4 showed good orientation and score. This novel compound represents potential scaffold for the design of clinically useful DPP IV inhibitors.
Keywords: Docking, DPP IV, Imidazolidine, Molecular modeling, Dipeptidyl Peptidase, oligopeptides, neuropeptides, insulinotropic action, cytokines, post-meal glycemic
Letters in Drug Design & Discovery
Title:Modeling Assisted In Silico Design of Ligand Molecule for DPP IV in Type II Diabetes Mellitus
Volume: 9 Issue: 8
Author(s): S. Amuthalakshmi, A. Anton Smith and R. Manavalan
Affiliation:
Keywords: Docking, DPP IV, Imidazolidine, Molecular modeling, Dipeptidyl Peptidase, oligopeptides, neuropeptides, insulinotropic action, cytokines, post-meal glycemic
Abstract: Type II diabetes Mellitus is one of the common diseases worldwide and often recognized as life style disease. The major symptom of this disease is an increase in blood glucose level resulting in polydypsia, polyuria and polyphagia. Molecular modeling was used to design the drug molecules. Docking results showed imidazolidine derivatives have good interaction with the DPP IV receptors. The compound IMA4 showed good orientation and score. This novel compound represents potential scaffold for the design of clinically useful DPP IV inhibitors.
Export Options
About this article
Cite this article as:
Amuthalakshmi S., Anton Smith A. and Manavalan R., Modeling Assisted In Silico Design of Ligand Molecule for DPP IV in Type II Diabetes Mellitus, Letters in Drug Design & Discovery 2012; 9 (8) . https://dx.doi.org/10.2174/157018012802652930
DOI https://dx.doi.org/10.2174/157018012802652930 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets Molecular Mechanisms of Renal Blood Flow Autoregulation
Current Vascular Pharmacology Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology HPLC and MS Analysis for the Identification and Characterisation of Peptides Presented in the Context of the Non-Classical Human Leukocytes Antigen (HLA) Class I Molecule HLA-E
Current Pharmaceutical Design The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Effect of a New Class of Compounds of the Group of Substituted 5R1, 6H2-1,3,4-thiadiazine-2-amines on the Inflammatory and Cytokine Response in Experimental Myocardial Infarction
Current Vascular Pharmacology Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs and Peroxisome Proliferator-Activated Receptors Governing the Differentiation of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy PPARs and Diabetes-Associated Atherosclerosis
Current Pharmaceutical Design HCN Channels Modulators: The Need for Selectivity
Current Topics in Medicinal Chemistry Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry Protein-Protein Interaction Inhibitors: Small Molecules from Screening Techniques
Current Topics in Medicinal Chemistry Mechanisms of Herb-Induced Nephrotoxicity
Current Medicinal Chemistry Biomarkers of Immunity and Inflammation for use in Nutrition Interventions: International Life Sciences Institute European Branch Work on Selection Criteria and Interpretation
Endocrine, Metabolic & Immune Disorders - Drug Targets GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer
Current Pharmaceutical Design Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Computational Protein Design: A Novel Path to Future Protein Drugs
Current Pharmaceutical Design RNA Interference: New Therapeutics in Allergic Diseases
Current Gene Therapy Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis
Current HIV Research Controlled-release Particulate Cytokine Adjuvants for Cancer Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets